Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection-Reference-Cited by-同舟云学术

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Published:2019-05 Issue:6 Volume:17 Page:1183-1191.e7
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Degasperi Elisabetta^ORCID,D’Ambrosio Roberta,Iavarone Massimo^ORCID,Sangiovanni Angelo,Aghemo Alessio,Soffredini Roberta,Borghi Marta,Lunghi Giovanna,Colombo Massimo,Lampertico Pietro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication;van der Meer;J Hepatol,2017

2. Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population;Bruno;J Hepatol,2016

3. The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy;D'Ambrosio;Antivir Ther,2011

4. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis;Cheung;J Hepatol,2016

5. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study;Romano;J Hepatol,2018

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver and spleen stiffness measurement in the prediction of hepatocellular carcinoma in chronic liver disease;Exploration of Digestive Diseases;2024-08-21

2. After the Storm: Persistent Molecular Alterations Following HCV Cure;International Journal of Molecular Sciences;2024-06-27

3. Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment;The Journal of Infection in Developing Countries;2024-05-30

4. Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis;Infectious Agents and Cancer;2024-04-25

5. Artificial intelligence in liver cancer — new tools for research and patient management;Nature Reviews Gastroenterology & Hepatology;2024-04-16